HIF-1 activation in hypoxic tumours enhances the expression of various glycolytic enzymes and glucose transporters such as lactate dehydrogenase-α and Glut1, facilitating increased glycolysis [5, 6]. The gene discussed is HIF1A; the disease is neoplasm.